34 Followers on Owler

Protalix

is an Israel-based biopharmaceutical company that develops and commercializes plant-based proteins for the treatment of fibrosis and inflammatory bowel diseases... Read more
OverviewCompetitorsFundingNews & Insights

Protalix

is an Israel-based biopharmaceutical company that develops and commercializes plant-based proteins for the treatment of fibrosis and inflammatory bowel diseases... Read more
Protalix President & CEO: Dror Bashan

President & CEO

Dror Bashan

CEO Approval Rating

87/100

1992

PublicNYSEPLX

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
$53.4M
Employees
200
Funding
$121.8M

News

Conference Presentation
Mar 25, 2025
Marketscreener
Protalix BioTherapeutics to Present at the iAccess Alpha Virtual Best Ideas Spring Conference 2025

Protalix Competitors

1Dyadic
2iBio
3Medicago
4Greenovation
5Crucell
6Icosavax
7MNPHARM
8KBI
9Tedor
10Alvotech
Unlock 11 + competitors

Trending Companies